Diabetes News

Endocrinology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Bergestuen DS et al. – Survival did not improve over the study period. Overall and relative 5–year survival compared favorably with that in population–based studies. Distant metastases, elevated chromogranin A levels, and advanced age were the only independent predictors of poor survival.


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address